Japanese encephalitis (JE) is inflammation of brain which is caused by Japanese encephalitis virus (JEV). This virus belongs to family Flaviviradae. JEV is considered as the most important cause of encephalitis in Asia. JEV is mosquito born flavivirus, belonging to same genus as dengue. It is spread by mosquitoes of Culex sp. Pig and birds are reservoirs of the virus and help in spreading and maintaining the JEV cycle. The disease caused by the virus has no cure. Effective vaccines are available which can prevent JE. JE vaccine is recommended to be integrated into national immunization schedule where JE disease is a public concern.
The global Japanese encephalitis vaccine market is estimated to grow at a significant rate over the forecast period. According to WHO, the estimated annual number of clinical cases of JE are about 68000 globally. Thus rise in prevalence and incidence of the disease is one of the most important factor expected to drive the growth of global Japanese encephalitis vaccine market during the forecast period. Furthermore, rise in awareness about the disease, increase in travel and tourism, government initiative to eradicate the disease, pig farming, entry of new vaccine manufacturers, developed R & D etc, increasing mosquito nuisance are few other factors fuelling the growth of the global Japanese encephalitis market through 2025. Factors such as stringent government regulation regarding efficacy and safety, lack of awareness lack of supply of the vaccine in remote areas can be the major restraining factors for global Japanese encephalitis vaccine market during the forecast period.
The global Japanese encephalitis vaccine market can be segmented into product type, distribution channel and regions. On the basis of product type, the global Japanese encephalitis vaccine market can be divided into mouse brain derived vaccine, live attenuated vaccine, live recombinant vaccine, inactivated Vero-cell derived vaccine. Vero cell derived vaccine segment is expected to account for a significant share of the market during the forecast period since mouse brain derived vaccine are being replaced cell based vaccine, due to higher efficacy and safety and animal ethical regulations. Based on the distribution channel the global JE vaccine market can be divided into hospital pharmacies, retail pharmacies and E-commerce.
Geographically the global Japanese encephalitis vaccine market is divided into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America is anticipated to dominate the human rabies vaccine market with the largest share during the forecast period. Surge in investment from government and public sector, programs to eradicate JE and yellow fever from the region etc are few factors propelling the growth of the global market in the North America. Furthermore, rise in awareness, robust research activities on yellow fever and JEV, high health care expenditure etc. are some other factors leading to market growth in the region. Asia Pacific market is anticipated to register a faster growth rate during the forecast period. The Asia Pacific is the most lucrative market due to high prevalence of the JE, government induced immunization programs, growing investment in R & D sector, entry of new vaccine manufacturers in the countries like India and China, increase number of travelers in the region, medical tourism etc. Furthermore, increase in pig farms, poultry and mosquito nuisance in the region etc, are some of the factors anticipated to drive the growth of market in the region.
Some of the prominent players operating in the global Japanese encephalitis vaccine market are Valneva SE, Bharat Biotech, Sanofi Pasteur SA, Biological E Chengdu Institute of Biological Products Co, Ltd and others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.